Tango Therapeutics Inc (NASDAQ: TNGX) is -66.16% lower on its value in year-to-date trading and has touched a low of $2.70 and a high of $13.01 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNGX stock was last observed hovering at around $3.38 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $3.35, the stock is -38.07% and -52.73% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.92 million and changing -0.89% at the moment leaves the stock -61.32% off its SMA200. TNGX registered -59.93% loss for a year compared to 6-month loss of -55.92%. The firm has a 50-day simple moving average (SMA 50) of $7.2391 and a 200-day simple moving average (SMA200) of $8.705625.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -51.02% gain in the last 1 month and extending the period to 3 months gives it a -63.98%, and is -35.33% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 23.54% over the week and 11.35% over the month.
Tango Therapeutics Inc (TNGX) has around 140 employees, a market worth around $359.85M and $43.38M in sales. Profit margin for the company is -284.43%. Distance from 52-week low is 24.07% and -74.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-46.75%).
with sales reaching $7.77M over the same period.The EPS is expected to shrink by -11.20% this year, but quarterly earnings will post 24.10% year-over-year. Quarterly sales are estimated to grow 43.10% in year-over-year returns.
Tango Therapeutics Inc (TNGX) Top Institutional Holders
182.0 institutions hold shares in Tango Therapeutics Inc (TNGX), with institutional investors hold 98.67% of the company’s shares. The shares outstanding are 102.20M, and float is at 62.35M with Short Float at 14.57%. Institutions hold 86.00% of the Float.
The top institutional shareholder in the company is TRV GP IV, LLC with over 19.2 million shares valued at $164.75 million. The investor’s holdings represent 17.751% of the TNGX Shares outstanding. As of 2024-06-30, the second largest holder is ECOR1 CAPITAL, LLC with 13.33 million shares valued at $114.38 million to account for 12.3237 of the shares outstanding. The other top investors are FMR LLC which holds 9.41 million shares representing 8.6983% and valued at over $80.73 million, while BOXER CAPITAL, LLC holds 7.5793 of the shares totaling 8.2 million with a market value of $70.34 million.
Tango Therapeutics Inc (TNGX) Insider Activity
The most recent transaction is an insider sale by EcoR1 Capital, LLC, the company’s 10% Owner. SEC filings show that EcoR1 Capital, LLC sold 1,494,558 shares of the company’s common stock on Nov 06 ’24 at a price of $3.28 per share for a total of $4.9 million. Following the sale, the insider now owns 11.84 million shares.
Tango Therapeutics Inc disclosed in a document filed with the SEC on Nov 07 ’24 that EcoR1 Capital, LLC (10% Owner) sold a total of 1,205,442 shares of the company’s common stock. The trade occurred on Nov 07 ’24 and was made at $2.94 per share for $3.54 million. Following the transaction, the insider now directly holds 10.63 million shares of the TNGX stock.
Still, SEC filings show that on Nov 06 ’24, Boxer Capital Management, LLC () disposed off 3,080,000 shares at an average price of $3.14 for $9.67 million. The insider now directly holds 3,610,642 shares of Tango Therapeutics Inc (TNGX).
